U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07244510) titled 'Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa' on Nov. 17.
Brief Summary: The purpose of this study is to assess efficacy, safety, pharmacokinetics and immunogenicity of subcutaneous SCT650C in patients with Moderate to Severe Hidradenitis Suppurativa
Study Start Date: Nov. 18
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa (HS)
Intervention:
DRUG: SCT650C
Administered SC
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sinocelltech Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....